(ANSA) - MADRID, 11 AUGUST - The Spanish Medicines Agency (Aemps) has authorized the start of human tests of an anti-Covid vaccine developed in the Iberian country. The manufacturing pharmaceutical company is the Hipra company. It is the first experimental vaccine produced in Spain to pass this new phase of study, according to a note from Aemps.
The human testing phase involves the participation of "several dozen volunteers" aged between 18 and 39, who will be given two doses over a 21-day time span.
The vaccine, explains Aemps, is based on an immune response generation mechanism similar to that used for the Novavax and Sanofi / Gsk vaccines.
"Today we are taking a big step forward in the fight against the pandemic," Spanish premier Pedro Sánchez rejoiced over the news on Twitter.
About ten days ago, AEMPS denied authorization for human trials of the experimental vaccine developed by the Spanish Superior Council of Scientific Research, from which more data on previous tests are expected in order to give the ok. (HANDLE).